![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Lifecore Biomedical (MM) | NASDAQ:LCBM | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 16.98 | 0 | 01:00:00 |
o Check the box if the filing relates solely to preliminary communications made before the commencement of a tender offer. |
ITEM 8. ADDITIONAL INFORMATION | ||||||||
ITEM 9. EXHIBITS | ||||||||
SIGNATURES | ||||||||
INDEX TO EXHIBITS |
Exhibit
Description
Press Release issued by SBT Holdings Inc. and SBT Acquisition Inc.
on March 21, 2008 (incorporated by reference to Exhibit (a)(1)(J)
to the Schedule TO-T/A filed by SBT Acquisition Inc., SBT Holdings
Inc. and Warburg Pincus Private Equity IX, L.P. on March 21, 2008)
LIFECORE BIOMEDICAL, INC.
|
||||
By: | /s/ Dennis J. Allingham | |||
Dennis J. Allingham | ||||
President and Chief Executive Officer | ||||
Exhibit No.
Offer to Purchase dated February 21, 2008 (incorporated by reference to
Exhibit (a)(1)(A) to the Tender Offer Statement on Schedule TO, filed by
Parent and Purchaser with respect to the Company on February 21, 2008 (the
Schedule TO
))
Letter of Transmittal dated February 21, 2008 (incorporated by reference to
Exhibit (a)(1)(B) to the Schedule TO)
Press Release issued by the Company dated January 15, 2008 (incorporated by
reference to the Schedule 14D-9C of the Company filed on January 15, 2008)
and Transcript of conference call by the Company on January 15, 2008
relating to the proposed acquisition of the Company by Parent (incorporated
by reference to the Schedule 14D-9C of the Company filed on January 15,
2008)
Press Release issued by the Company dated February 14, 2008 (incorporated by
reference to the Schedule TO-C filed by the Company on February 14, 2008)
Press Release issued by Parent and Purchaser dated January
15, 2008 (incorporated by reference to the Schedule TO-C
filed by the Company on January 15, 2008)
Summary Advertisement published in The New York Times dated
February 21, 2008 (incorporated by reference to Exhibit
(a)(1)(I) to the Schedule TO)
Letter to Shareholders of the Company dated February 21, 2008
Letter to Brokers, Dealers, Commercial Banks, Trust
Companies and Other Nominees (incorporated by reference to
Exhibit (a)(1)(D) to the Schedule TO)
Letter to Clients for Use by Brokers, Dealers, Commercial
Banks, Trust Companies and Other Nominees (incorporated by
reference to Exhibit (a)(1)(E) to the Schedule TO)
Notice of Guaranteed Delivery (incorporated by reference to
Exhibit (a)(1)(C) to the Schedule TO)
Memorandum from the Company to all Option Holders dated
February 26, 2008
Exhibit No. | ||
|
||
Exhibit (a)(12)
|
Press Release issued by SBT Holdings Inc. and SBT Acquisition Inc. on March 21, 2008 (incorporated by reference to Exhibit (a)(1)(J) to the Schedule TO-T/A filed by SBT Acquisition Inc., SBT Holdings Inc. and Warburg Pincus Private Equity IX, L.P. on March 21, 2008) | |
|
||
Exhibit (e)(1)*
|
Opinion of Piper Jaffray & Co. dated February 14, 2008 (incorporated by reference to Annex B of this Schedule 14D-9) | |
|
||
Exhibit (e)(2)*
|
Agreement and Plan of Merger dated as of January 15, 2008, among Parent, Purchaser and the Company (incorporated by reference to Exhibit (d)(1)(A) to the Schedule TO) | |
|
||
Exhibit (e)(3)*
|
The Information Statement of the Company dated as of February 21, 2008 (incorporated by reference to Annex A of this Schedule 14D-9) | |
|
||
Exhibit (e)(4)*
|
Confidentiality Agreement between Parent and the Company dated July 21, 2006 (incorporated by reference to Exhibit (d)(1)(C) to the Schedule TO) | |
|
||
Exhibit (e)(5)*
|
Form of Change in Control Agreement between the Company and certain executive officers of the Company (incorporated by reference to Exhibit 10.3 to the Companys Quarterly Report on Form 10-Q for the fiscal quarter ended September 30, 2004) | |
|
||
Exhibit (e)(6)*
|
Change in Control Agreement dated June 17, 2004, between the Company and Dennis J. Allingham (incorporated by reference to Exhibit 10.4 to the Companys Quarterly Report on Form 10-Q for the fiscal quarter ended September 30, 2004) | |
|
||
Exhibit (g)*
|
None |
* | Previously filed. |
1 Year Lifecore Biomedical (MM) Chart |
1 Month Lifecore Biomedical (MM) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions